Anticancer effect of nor-wogonin (5, 7, 8-trihydroxyflavone) on human triple-negative breast cancer cells via downregulation of TAK1, NF-κB, and STAT3

被引:30
作者
Abd El-Hafeez, Amer Ali [1 ,2 ,3 ]
Khalifa, Hazim O. [4 ,5 ]
Mahdy, Elham A. M. [6 ]
Sharma, Vikas [7 ]
Hosoi, Toru [1 ]
Ghosh, Pradipta [8 ,9 ,10 ]
Ozawa, Koichiro [1 ]
Montano, Monica M. [7 ]
Fujimura, Takashi [11 ]
Ibrahim, Ahmed R. N. [12 ]
Abdelhamid, Mohamed A. A. [13 ,14 ]
Pack, Seung Pil [14 ]
Shouman, Samia A. [3 ]
Kawamoto, Seiji [11 ]
机构
[1] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Pharmacotherapy, Hiroshima, Japan
[2] Hiroshima Univ, Global Career Design Ctr, Hiroshima, Japan
[3] Cairo Univ, Natl Canc Inst, Dept Canc Biol, Pharmacol & Expt Oncol Unit, Cairo, Egypt
[4] Kafrelsheikh Univ, Fac Vet Med, Dept Pharmacol, Kafrelsheikh, Egypt
[5] Int Univ Hlth & Welf, Grad Sch Med, Dept Infect Dis, Narita, Japan
[6] Beni Suef Univ, Fac Pharm, Bani Suwayf, Egypt
[7] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA
[8] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA
[9] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA
[10] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA
[11] Hiroshima Univ, Grad Sch Adv Sci Matter, Dept Mol Biotechnol, Hiroshima Res Ctr Hlth Aging HiHA, Hiroshima, Japan
[12] Minia Univ, Fac Pharm, Dept Biochem, Al Minya, Egypt
[13] Minia Univ, Fac Sci, Dept Bot & Microbiol, Al Minya, Egypt
[14] Korea Univ, Dept Biotechnol & Bioinformat, Sejong, South Korea
关键词
Breast cancer; Nor-wogonin; Apoptosis; Cell cycle arrest; Multi-target flavone; CYCLE ARREST; TRANSCRIPTIONAL REGULATION; SCUTELLARIA-BAICALENSIS; APOPTOSIS; ACTIVATION; BAX; MITOCHONDRIA; MODULATION; EXTRACT; GROWTH;
D O I
10.1016/j.pharep.2019.01.001
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Nor-wogonin, a polyhydroxy flavone, has been shown to possess antitumor activity. However, the mechanisms responsible for its antitumor activity are poorly studied. Herein, we investigated the mechanisms of nor-wogonin actions in triple-negative breast cancer (TNBC) cells. Methods: Effects of nor-wogonin on cell proliferation and viability of four TNBC cell lines (MDA-MB-231, BT-549, HCC70, and HCC1806) and two non-tumorigenic breast cell lines (MCF-10A and AG11132) were assessed by BrdU incorporation assays and trypan blue dye exclusion tests. Cell cycle and apoptosis analyses were carried out by flow cytometry. Protein expression was analyzed by immunoblotting. Results: Nor-wogonin significantly inhibited the growth and decreased the viability of TNBC cells; however, it exhibited no or minimal effects in non-tumorigenic breast cells. Nor-wogonin (40 mu M) was a more potent anti-proliferative and cytotoxic agent than wogonin (100 mu M) and wogonoside (100 mu M), which are structurally related to nor-wogonin. The antitumor effects of nor-wogonin can be attributed to cell cycle arrest via reduction of the expression of cyclin D1, cyclin B1, and CDK1. Furthermore, norwogonin induced mitochondrial apoptosis, (as evidenced by the increase in % of cells that are apoptotic), decreases in the mitochondrial membrane potential (Delta Psi m), increases in Bax/Bcl-2 ratio, and caspase-3 cleavage. Moreover, nor-wogonin attenuated the expression of the nuclear factor kappa-B and activation of signal transducer and activator of transcription 3 pathways, which can be correlated with suppression of transforming growth factor-beta-activated kinase 1 in TNBC cells. Conclusion: These results showed that nor-wogonin might be a potential multi-target agent for TNBC treatment. (C) 2019 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:289 / 298
页数:10
相关论文
共 47 条
[1]   Melilotus indicus extract induces apoptosis in hepatocellular carcinoma cells via a mechanism involving mitochondria-mediated pathways [J].
Abd El-Hafeez, Amer Ali ;
Khalifa, Hazim O. ;
Elgawish, Rania Abdelrahman ;
Shouman, Samia A. ;
Abd El-Twab, Magdy Hussein ;
Kawamoto, Seiji .
CYTOTECHNOLOGY, 2018, 70 (02) :831-842
[2]   Separation, upgrading, and mineralogy of placer magnetite in the black sands, northern coast of Egypt [J].
Abdel-Karim, Abdel-Aal M. ;
Barakat, Mohamed G. .
ARABIAN JOURNAL OF GEOSCIENCES, 2017, 10 (14)
[3]   Antiproliferative and cytostatic effects of the natural product eupatorin on MDA-MB-468 human breast cancer cells due to CYP1-mediated metabolism [J].
Androutsopoulos, Vasilis ;
Arroo, Randolph R. J. ;
Hall, John F. ;
Surichan, Somchaiya ;
Potter, Gerry A. .
BREAST CANCER RESEARCH, 2008, 10 (03)
[4]  
Assoian Richard K., 1997, Cytokine and Growth Factor Reviews, V8, P165, DOI 10.1016/S1359-6101(97)00011-7
[5]   Constitutive activation of STAT3 in breast cancer cells: A review [J].
Banerjee, Kasturi ;
Resat, Haluk .
INTERNATIONAL JOURNAL OF CANCER, 2016, 138 (11) :2570-2578
[6]   Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease [J].
Bianchini, Giampaolo ;
Balko, Justin M. ;
Mayer, Ingrid A. ;
Sanders, Melinda E. ;
Gianni, Luca .
NATURE REVIEWS CLINICAL ONCOLOGY, 2016, 13 (11) :674-690
[7]   Proapoptotic Bax and Bak Proteins Form Stable Protein-permeable Pores of Tunable Size [J].
Bleicken, Stephanie ;
Landeta, Olatz ;
Landajuela, Ane ;
Basanez, Gorka ;
Garcia-Saez, Ana J. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (46) :33241-33252
[8]   BID regulates AIF-mediated caspase-independent necroptosis by promoting BAX activation [J].
Cabon, L. ;
Galan-Malo, P. ;
Bouharrour, A. ;
Delavallee, L. ;
Brunelle-Navas, M-N ;
Lorenzo, H. K. ;
Gross, A. ;
Susin, S. A. .
CELL DEATH AND DIFFERENTIATION, 2012, 19 (02) :245-256
[9]   Elevated TAK1 augments tumor growth and metastatic capacities of ovarian cancer cells through activation of NF-κB signaling [J].
Cai, Patty C. H. ;
Shi, Lei ;
Liu, Vincent W. S. ;
Tang, Hermit W. M. ;
Liu, Iris J. ;
Leung, Thomas H. Y. ;
Chan, Karen K. L. ;
Yam, Judy W. P. ;
Yao, Kwok-Ming ;
Ngan, Hextan Y. S. ;
Chan, David W. .
ONCOTARGET, 2014, 5 (17) :7549-7562
[10]   Transcriptional regulation of bcl-2 by nuclear factor κB and its significance in prostate cancer [J].
Catz, SD ;
Johnson, JL .
ONCOGENE, 2001, 20 (50) :7342-7351